Erika Hutz, - Medicare Internal Medicine in Chicago, IL

Erika Hutz, is a medicare enrolled "Internal Medicine" physician in Chicago, Illinois. She graduated from medical school in 2015 and has 9 years of diverse experience with area of expertise as Internal Medicine. She is a member of the group practice North Shore University Healthsystem Faculty Practice Associates, Swedish Covenant Management Services Inc and her current practice location is 5145 N California Ave, Chicago, Illinois. You can reach out to her office (for appointments etc.) via phone at (773) 878-8200.

Erika Hutz is licensed to practice in Illinois (license number 036145954) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1821481607.

Contact Information

Erika Hutz,
5145 N California Ave,
Chicago, IL 60625-3661
(773) 878-8200
Not Available



Physician's Profile

Full NameErika Hutz
GenderFemale
SpecialityInternal Medicine
Experience9 Years
Location5145 N California Ave, Chicago, Illinois
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Erika Hutz graduated from medical school in 2015
  NPI Data:
  • NPI Number: 1821481607
  • Provider Enumeration Date: 03/18/2015
  • Last Update Date: 10/30/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 5395177927
  • Enrollment ID: I20191119002842

Medical Identifiers

Medical identifiers for Erika Hutz such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1821481607NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RG0300XInternal Medicine - Geriatric Medicine 036145954 (Illinois)Secondary
390200000XStudent In An Organized Health Care Education/training Program (* (Not Available))Secondary
207R00000XInternal Medicine 036145954 (Illinois)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Northshore University Healthsystem Home & HospiceSkokie, ILHome health agency
O & P Home Health Care, IncSkokie, ILHome health agency
Choice Home Health Services, IncBloomingdale, ILHome health agency
Home Healthcare Solutions Compnay LlcOak lawn, ILHome health agency
Northshore University Healthsystem - Evanston HospitalEvanston, ILHospital
Swedish Covenant HospitalChicago, ILHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
North Shore University Healthsystem Faculty Practice Associates21633346991751
Swedish Covenant Management Services Inc4486556016111

News Archive

Gene-therapy trial to restore hearing in deaf mice

Researchers have found long-sought genes in the sensory hair cells of the inner ear that, when mutated, prevent sound waves from being converted to electric signals - a fundamental first step in hearing. The team, co-led by Jeffrey Holt, PhD, in the department of otolaryngology at Children-s Hospital Boston, and Andrew Griffith, MD, PhD, of the NIH-s National Institute on Deafness and other Communication Disorders (NIDCD), then restored these electrical signals in the sensory cells of deaf mice by introducing normal genes.

Incidence of TBI likely greater than previously estimated

Though researchers are becoming increasingly aware of the long-term effects of head injury, few studies have looked at the prevalence of traumatic brain injury (TBI) in all age groups, including males and females, taking into account both mild and serious events. In a recent study published in Epidemiology, Mayo Clinic researchers applied a new, refined system for classifying injuries caused by force to the head and found that the incidence of traumatic brain injury is likely greater than has been estimated by the Centers for Disease Control and Prevention.

First-ever nivolumab drug trial for rare, malignant SCCA shows positive results

A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab.

Scientists improve immune response to cancer

A team of scientists at The Campbell Family Institute for Breast Cancer Research (CFIBCR) at Princess Margaret Hospital and international collaborators have discovered how to trigger an improved immune response to cancer that could be included in new clinical trials that use a patient's own cells to destroy tumours.

Blood test helps in identifying markers of COVID-19

Researchers from the Institute of Biomedicine of Seville (IBIS) have presented a study carried out in the Clinical Biochemistry Service of the Virgen del Rocío University Hospital which identifies the values for six biochemical biomarkers that indicate a patient may be infected with SARS-COV-2 (COVID-19).

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Erika Hutz allows following entities to bill medicare on her behalf.
Entity NameSwedish Covenant Management Services Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1760432348
PECOS PAC ID: 4486556016
Enrollment ID: O20040123000850

News Archive

Gene-therapy trial to restore hearing in deaf mice

Researchers have found long-sought genes in the sensory hair cells of the inner ear that, when mutated, prevent sound waves from being converted to electric signals - a fundamental first step in hearing. The team, co-led by Jeffrey Holt, PhD, in the department of otolaryngology at Children-s Hospital Boston, and Andrew Griffith, MD, PhD, of the NIH-s National Institute on Deafness and other Communication Disorders (NIDCD), then restored these electrical signals in the sensory cells of deaf mice by introducing normal genes.

Incidence of TBI likely greater than previously estimated

Though researchers are becoming increasingly aware of the long-term effects of head injury, few studies have looked at the prevalence of traumatic brain injury (TBI) in all age groups, including males and females, taking into account both mild and serious events. In a recent study published in Epidemiology, Mayo Clinic researchers applied a new, refined system for classifying injuries caused by force to the head and found that the incidence of traumatic brain injury is likely greater than has been estimated by the Centers for Disease Control and Prevention.

First-ever nivolumab drug trial for rare, malignant SCCA shows positive results

A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab.

Scientists improve immune response to cancer

A team of scientists at The Campbell Family Institute for Breast Cancer Research (CFIBCR) at Princess Margaret Hospital and international collaborators have discovered how to trigger an improved immune response to cancer that could be included in new clinical trials that use a patient's own cells to destroy tumours.

Blood test helps in identifying markers of COVID-19

Researchers from the Institute of Biomedicine of Seville (IBIS) have presented a study carried out in the Clinical Biochemistry Service of the Virgen del Rocío University Hospital which identifies the values for six biochemical biomarkers that indicate a patient may be infected with SARS-COV-2 (COVID-19).

Read more Medical News

› Verified 9 days ago

Entity NameNorthshore University Healthsystem Faculty Practice Associates
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1497701882
PECOS PAC ID: 2163334699
Enrollment ID: O20040524000118

News Archive

Gene-therapy trial to restore hearing in deaf mice

Researchers have found long-sought genes in the sensory hair cells of the inner ear that, when mutated, prevent sound waves from being converted to electric signals - a fundamental first step in hearing. The team, co-led by Jeffrey Holt, PhD, in the department of otolaryngology at Children-s Hospital Boston, and Andrew Griffith, MD, PhD, of the NIH-s National Institute on Deafness and other Communication Disorders (NIDCD), then restored these electrical signals in the sensory cells of deaf mice by introducing normal genes.

Incidence of TBI likely greater than previously estimated

Though researchers are becoming increasingly aware of the long-term effects of head injury, few studies have looked at the prevalence of traumatic brain injury (TBI) in all age groups, including males and females, taking into account both mild and serious events. In a recent study published in Epidemiology, Mayo Clinic researchers applied a new, refined system for classifying injuries caused by force to the head and found that the incidence of traumatic brain injury is likely greater than has been estimated by the Centers for Disease Control and Prevention.

First-ever nivolumab drug trial for rare, malignant SCCA shows positive results

A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab.

Scientists improve immune response to cancer

A team of scientists at The Campbell Family Institute for Breast Cancer Research (CFIBCR) at Princess Margaret Hospital and international collaborators have discovered how to trigger an improved immune response to cancer that could be included in new clinical trials that use a patient's own cells to destroy tumours.

Blood test helps in identifying markers of COVID-19

Researchers from the Institute of Biomedicine of Seville (IBIS) have presented a study carried out in the Clinical Biochemistry Service of the Virgen del Rocío University Hospital which identifies the values for six biochemical biomarkers that indicate a patient may be infected with SARS-COV-2 (COVID-19).

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Erika Hutz is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Erika Hutz,
5145 N California Ave,
Chicago, IL 60625-3661

Ph: () -
Erika Hutz,
5145 N California Ave,
Chicago, IL 60625-3661

Ph: (773) 878-8200

News Archive

Gene-therapy trial to restore hearing in deaf mice

Researchers have found long-sought genes in the sensory hair cells of the inner ear that, when mutated, prevent sound waves from being converted to electric signals - a fundamental first step in hearing. The team, co-led by Jeffrey Holt, PhD, in the department of otolaryngology at Children-s Hospital Boston, and Andrew Griffith, MD, PhD, of the NIH-s National Institute on Deafness and other Communication Disorders (NIDCD), then restored these electrical signals in the sensory cells of deaf mice by introducing normal genes.

Incidence of TBI likely greater than previously estimated

Though researchers are becoming increasingly aware of the long-term effects of head injury, few studies have looked at the prevalence of traumatic brain injury (TBI) in all age groups, including males and females, taking into account both mild and serious events. In a recent study published in Epidemiology, Mayo Clinic researchers applied a new, refined system for classifying injuries caused by force to the head and found that the incidence of traumatic brain injury is likely greater than has been estimated by the Centers for Disease Control and Prevention.

First-ever nivolumab drug trial for rare, malignant SCCA shows positive results

A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab.

Scientists improve immune response to cancer

A team of scientists at The Campbell Family Institute for Breast Cancer Research (CFIBCR) at Princess Margaret Hospital and international collaborators have discovered how to trigger an improved immune response to cancer that could be included in new clinical trials that use a patient's own cells to destroy tumours.

Blood test helps in identifying markers of COVID-19

Researchers from the Institute of Biomedicine of Seville (IBIS) have presented a study carried out in the Clinical Biochemistry Service of the Virgen del Rocío University Hospital which identifies the values for six biochemical biomarkers that indicate a patient may be infected with SARS-COV-2 (COVID-19).

Read more News

› Verified 9 days ago


Internal Medicine Doctors in Chicago, IL

Dr. Sorin C Danciu, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 3134 N Clark St, Chicago, IL 60657
Phone: 773-880-9722    
Anoopa A. Koshy, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 259 E Erie St Ste 2200, Chicago, IL 60611
Phone: 312-926-6000    
William Edmond Gerardi, M.D.
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 3730 N Lake Shore Dr, Apartment 2a, Chicago, IL 60613
Phone: 773-244-3060    
Suparna Dutta, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1700 W Van Buren St, Suite 500, Chicago, IL 60612
Phone: 312-942-4200    Fax: 312-942-3568
Alexandra Dumitrescu,
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 5841 S Maryland Ave, Chicago, IL 60637
Phone: 888-824-0200    
Dr. Mitesh Mahesh Kabadi, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1725 W Harrison St Ste 1159, Chicago, IL 60612
Phone: 312-942-5020    
Dr. Marta Batus, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1725 W Harrison St, Suite 809, Chicago, IL 60612
Phone: 312-563-2487    Fax: 312-942-3192

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.